253 related articles for article (PubMed ID: 15519745)
1. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T
Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745
[TBL] [Abstract][Full Text] [Related]
2. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease.
Tilley L; Morgan K; Grainger J; Marsters P; Morgan L; Lowe J; Xuereb J; Wischik C; Harrington C; Kalsheker N
Eur J Hum Genet; 1999 Sep; 7(6):659-63. PubMed ID: 10482954
[TBL] [Abstract][Full Text] [Related]
4. No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese.
Lee DW; Liu HC; Liu TY; Chi CW; Hong CJ
Am J Med Genet; 2000 Apr; 96(2):167-9. PubMed ID: 10893490
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
6. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
7. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
[TBL] [Abstract][Full Text] [Related]
8. Allele epsilon 4 of APOE is a stronger predictor of Alzheimer risk in Sicily than in continental South Italy.
Bosco P; Guéant-Rodríguez RM; Anello G; Spada RS; Romano A; Caraci F; Ferri R; Guéant JL
Neurosci Lett; 2005 Nov; 388(3):168-72. PubMed ID: 16040191
[TBL] [Abstract][Full Text] [Related]
9. [An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population].
Wu YN; Zhang JW; Zhang ZX; Qu QM; Chen D
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Oct; 23(5):450-4. PubMed ID: 12905860
[TBL] [Abstract][Full Text] [Related]
10. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
[TBL] [Abstract][Full Text] [Related]
11. Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland.
McIlroy SP; Crawford VL; Dynan KB; McGleenon BM; Vahidassr MD; Lawson JT; Passmore AP
J Med Genet; 2000 Mar; 37(3):182-5. PubMed ID: 10699053
[TBL] [Abstract][Full Text] [Related]
12. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
Beyer K; Lao JI; Latorre P; Ariza A
Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900
[TBL] [Abstract][Full Text] [Related]
13. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.
Osuntokun BO; Sahota A; Ogunniyi AO; Gureje O; Baiyewu O; Adeyinka A; Oluwole SO; Komolafe O; Hall KS; Unverzagt FW
Ann Neurol; 1995 Sep; 38(3):463-5. PubMed ID: 7668835
[TBL] [Abstract][Full Text] [Related]
14. [Apolipoprotein E gene polymorphisms and Alzheimer disease].
Chen D; Zhang JW; Zhang ZX; Zhao HL; Li XQ; Wu YN; Qu QM
Yi Chuan Xue Bao; 2003 Dec; 30(12):1167-70. PubMed ID: 14986436
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies.
Nalbantoglu J; Gilfix BM; Bertrand P; Robitaille Y; Gauthier S; Rosenblatt DS; Poirier J
Ann Neurol; 1994 Dec; 36(6):889-95. PubMed ID: 7998776
[TBL] [Abstract][Full Text] [Related]
16. D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals.
Zubenko GS; Hughes HB; Stiffler JS
Mol Psychiatry; 2001 Jul; 6(4):413-9. PubMed ID: 11443525
[TBL] [Abstract][Full Text] [Related]
17. Increased risk for Alzheimer disease with the interaction of MPO and A2M polymorphisms.
Zappia M; Manna I; Serra P; Cittadella R; Andreoli V; La Russa A; Annesi F; Spadafora P; Romeo N; Nicoletti G; Messina D; Gambardella A; Quattrone A
Arch Neurol; 2004 Mar; 61(3):341-4. PubMed ID: 15023809
[TBL] [Abstract][Full Text] [Related]
18. [Genetic association between the apolipoprotein E (ApoE) gene alleles and various forms of Alzheimer's disease].
Korovaĭtseva GI; Shcherbatykh TV; Selezneva NV; Gavrilova SI; Golimbet VE; Voskresenskaia NI; Rogaev EI
Genetika; 2001 Apr; 37(4):529-35. PubMed ID: 11421127
[TBL] [Abstract][Full Text] [Related]
19. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.
Lehmann DJ; Johnston C; Smith AD
Hum Mol Genet; 1997 Oct; 6(11):1933-6. PubMed ID: 9302273
[TBL] [Abstract][Full Text] [Related]
20. Improved prediction of early-onset coronary artery disease using APOE epsilon4, BChE-K, PPARgamma2 Pro12 and ENOS T-786C in a polygenic model.
Nassar BA; Rockwood K; Kirkland SA; Ransom TP; Darvesh S; MacPherson K; Johnstone DE; O'Neill BJ; Bata IR; Andreou P; Jeffery JS; Cox JL; Title LM
Clin Biochem; 2006 Feb; 39(2):109-14. PubMed ID: 16298355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]